Catalyst Wire Dossier Catalyst Wire Dossier

Dual-sided hypoglossal nerve stimulation device (DREAM)

hypoglossal nerve stimulation · Nyxoah S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dual-sided hypoglossal nerve stimulation device (DREAM), covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM) [NA]

See pricing